Myogenic signaling by lithium in cardiomyoblasts is Akt independent but requires activation of the β-catenin-Tcf/Lef pathway

Journal of Molecular and Cellular Cardiology

Volumn 35, Issue 8, 2003, Pages 937-951

  Kashour, Tarek ^a   Burton, Teralee ^b,c   Dibrov, Alexander ^d   Amara, Francis ^b,c  

^a ST BONIFACE GENERAL HOSPITAL   (Canada)

^b ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d Fort Richond Collegiate   (Canada)

Author keywords

H9c2 cardiomyoblasts; Lithium; Muscle differentiation; Phosphatidylinositol 3 kinase; Protein kinase B Akt; Catenin

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ALPHA ACTIN; BETA CATENIN; LITHIUM; MYOGENIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; DRUG EFFECT; ENZYME ACTIVATION; HEART MUSCLE CELL; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SERUM; SIGNAL TRANSDUCTION;

EID: 0038148758     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2828(03)00176-7     Document Type: Article

References (50)

1. Molkentin J., Olson E.N. Combinatorial control of muscle development by basic helix- loop-helix and MADS-box transcription factors. Proc Natl Acad Sci USA. 93:1996;9366-9373.
2. Yun K., Wold B. Skeletal muscle determination and differentiation: story of a core regulatory network and its context. Curr Opin Cell Biol. 8:1996;877-889.
3. Munsterberg A.E., Kitajewski J., Burmcrot D.A., Macmahon A.P., Lassar A.B. Combinatorial signaling by Sonic hedgehog and Wnt family members induces myogenic bHLH gene expression in the somite. Genes Dev. 9:1995;2911-2922.
4. Stern H.M., Brown A.M., Hauschka S.D. Myogenesis in paraxial mesoderm: preferential induction by dorsal neural tube and by cells expressing Wnt-1. Development. 121:1995;3675-3686.
5. Hoppler S., Brown J.D., Moon R.T. Expression of a dominant-negative Wnt blocks induction of MyoD in Xenopus embryos. Gene Dev. 10:1996;2805-2817.
6. Ikeya M., Takada S. Wnt signaling from the dorsal neural tube is required for the formation of the medial dermomyotome. Development. 125:1998;4969-4976.
7. Tajbakhsh S., Borello U., Vivarelli R., Kelly J., Papkoff D., Buckingham M., et al. Differential activation of Myf5 and MyoD by different Wnts in explants of mouse paraxial mesoderm and the later activation of myogenesis in the absence of Myf5. Development. 125:1998;4155-4162.
8. Borello U., Coletta M., Tajbakhsh S., Leyns L., De robertis E.M., Buckingham M., et al. Transplacental delivery of the Wnt antagonist Frzb1 inhibits development of caudal paraxial mesoderm and skeletal myogenesis in mouse embryos. Development. 126:1999;4247-4255.
9. Wagner J., Schmidt C., Nikowits W. Jr, Christ B. Compartmentalization of the somite and myogenesis in chick embryos are influenced by wnt expression. Dev Biol. 228:2000;86-94.
10. Kaliman P., Vinals X., Testar M., Palacin M., Zorzano A. Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J Biol Chem. 271:1996;19146-19151.
11. Jiang B.H., Zheng Z., Vogt P.K. An essential role of phosphatidylinositol 3-kinase in myogenic differentiation. Proc Natl Acad Sci USA. 95:1998;14179-14183.
12. Kaliman P., Canicio J., Shepherd P.R., Beeton C.A., Testar M., Palacin M., et al. Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: dominant negative p85 expression blocks differentiation of L6E9 muscle cells. Mol Endocrinol. 12:1998;66-77.
13. Kim J.M., Yoon M.Y., Kim J., Kim S.S., Kang I., Ha J. Phosphatidylinositol 3-kinase regulates differentiation of H9c2 cardiomyoblasts mainly through the protein kinase B/Akt-independent pathway. Arch Biochem Biophys. 367:1999;67-73.
14. Jiang B.H., Aoki M., Zheng J.Z., Li J., Vogt P.K. Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B. Proc Natl Acad Sci USA. 96:1999;2077-2081.
15. Xu Q., Wu Z. The insulin-like growth factor-phosphatidylinositol 3-kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in rhabdomyosarcoma-derived RD cells. J Biol Chem. 275:2000;36750-36757.
16. Brennan T.J., Edmondson D.J., Li L., Olson E.N. Transforming growth factor beta represses the actions of myogenin through a mechanism independent of DNA binding. Proc Natl Acad Sci USA. 88:1991;3822-3826.
17. Li L., Zhou J., James R., Heller-Harrison R., Czech M.P., Olson E.N. FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell. 71:1992;1181-1194.
18. Klein P.S., Melton D.A. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA. 93:1996;8455-8459.
19. Chalecka-Franaszek E., Chuang D.M. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc Natl Acad Sci USA. 96:1999;8745-8750.
20. Ohtekei T., Parsons M., Zakarian A., Jones R.G., Nguyen L.T., Woodgett J.R., et al. Negative regulation of T cell proliferation and interleukin 2 production by the serine threonine kinase GSK-3. Exp M. 192:2000;99-104.
21. Smits V.A., Essers M.A., Loomans D.S., Klompmaker R., Rijksen G., Medema R.H. Inhibition of cell proliferation by lithium is associated with interference in cdc2 activation. FEBS Lett. 457:1999;23-27.
22. Garcia-Perez J., Avila J., Diaz-Nido J. Lithium induces morphological differentiation of mouse neuroblastoma cells. Neurosci Res. 57:1999;261-270.
23. Roos S.E., Hemati N., Longo K.A., Bennett C.N., Lucas P.C., Erickson R.L., et al. Inhibition of adipogenesis by Wnt signaling. Science. 289:2000;950-953.
24. Lee K.H., Kim D.G., Shin M.N., Song W.K., Kwon K., Chung C.H., et al. NF-kappaB-dependent expression of nitric oxide synthase is required for membrane fusion of chick embryonic myoblasts. Biochem J. 324:1997;237-242.
25. Nonaka S., Hough C.J., Chuang D.M. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc Natl Acad Sci USA. 95:1998;2642-2647.
26. D'Mello S.R., Borodezt K., Soltoff S.P. Insulin-like growth factor and potassium depolarization maintain neuronal survival by distinct pathways: possible involvement of PI 3-kinase in IGF-1 signaling. J Neurosci. 17:1997;1548-1560.
27. Zhang F.X., Rubin R., Roney T.A. N-methyl-D-aspartate inhibits apoptosis through activation of phosphatidylinositol 3-kinase in cerebellar granule neurons. A role for insulin receptor substrate-1 in the neurotrophic action of N-methyl-D-aspartate and its inhibition by ethanol. J Biol Chem. 273:1998;13150-13156.
28. Dyer R.B., Herzog N.K. Isolation of intact nuclei for nuclear extract preparation from a fragile B-lymphocyte cell line. Biotechniques. 19:1995;192.
29. Korinek V., Barker N., Morin P.J., van Wichen D., De Weger R., Kinzler K.W., et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science. 275:1997;1784-1787.
30. Gorman C. Thin layer chromatography assay of Chloramphenicol acetyltransferase activity, in: DNA Cloning (IRL Press) 1985;2:143-9.
31. Kimes B.W., Brandt B.L. Properties of a clonal muscle cell line from rat heart. Exp Cell Res. 98:1976;367-381.
32. Vandrome M., Rochat A., Meier R., Carnac G., Besser D., Hemming B.A., et al. Protein kinase B beta/Akt2 plays a specific role in muscle differentiation. J Biol Chem. 276:2001;8173-8179.
33. Fukomoto S., Hsieh C.M., Maemura K., Layne M.D., Yet S.F., Lee K.H., et al. Akt participation in the Wnt signaling pathway through dishevelled. J Biol Chem. 276:2001;17479-17483.
34. Fujio Y., Guo K., Mano T., Mitsuuchi Y., Testa J.R., Walsh K. Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival. Mol Cell Biol. 19:1999;5073-5082.
35. Altomare D.A., Lyons G.E., Mitsuuchi Y., Cheng J.Q., Testa J.R. Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin. Oncogene. 16:1998;2407-2411.
36. Calera M.R., Pilch P.R. Induction of Akt-2 correlates with differentiation in Sol8 muscle cells. Biochem Biophys Res Commun. 251:1998;835-841.
37. Delling U., Tureckova J., Lim H.W., De Windt L.J., Rotwein P., Molkentin J.D. A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression. Mol Cell Biol. 20:2000;6600-6611.
38. Beals C.R., Sheridan C.M., Turck C.W., Gardner P., Crabtree G.R. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science. 275:1997;1930-1934.
39. Neal J.W., Clipstone N.A. Glycogen synthase kinase-3 inhibits the DNA binding activity of NFATc. J Biol Chem. 276:2001;3666-3673.
40. Haq S., Choukroun G., Kang Z.B., Ranu H., Matsui T., Rosenweig A., et al. Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy. Cell Biol. 151:2000;117-130.
41. Walsh K., Perlman H. Cell cycle exits upon myogenic differentiation. Curr Opin Genet Dev. 7:1997;597-602.
42. Porello A., Cerone M.A., Coen S., Gurner A., Fontemmaggi G., Cimino L., et al. p53 regulates myogenesis by triggering the differentiation activity of pRb. J Cell Biol. 151:2000;1295-1304.
43. Mao C.D., Hoang P., Dicorleto P.E. Lithium inhibits cell cycle progression and induces stabilization of p53 in bovine aortic endothelial cells. J Biol Chem. 276:2001;26180-26188.
44. Lu J., Mackinsey T.A., Zhang C.L., Olson E.N. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol Cell. 6:2000;233-244.
45. Espada J., Perez-Moreno M., Braga V.M.M., Rodriguez-Viciana P., Cano A. H-Ras activation promotes cytoplasmic accumulation and phosphoinositide 3-OH kinase association of beta-catenin in epidermal keratinocytes. J Cell Biol. 146:1999;967-980.
46. Adam L., Vadlamudi R.K., Mcrea P., Kumar R. Tiam1 overexpression potentiates heregulin-induced lymphoid enhancer factor-1/beta-catenin nuclear signaling in breast cancer cells by modulating the intercellular stability. J Biol Chem. 276:2001;28443-28450.
47. Chen R.H., Ding W.V., McCormick F. Wnt signaling to beta-catenin involves two interactive components. Glycogen synthase kinase-3beta inhibition and activation of protein kinase C. J Biol Chem. 275:2000;17894-17899.
48. Torres M.A., Eldar-Finkelman H., Krebs E.G., Moon R.T. Regulation of ribosomal S6 protein kinase-p90(rsk), glycogen synthase kinase 3, and beta-catenin in early Xenopus development. Mol Cell Biol. 19:1999;1427-1437.
49. Persad S., Troussard A.A., McPhee T.R., Muholland D.J., Dedhar S. Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation. J Cell Biol. 153:2001;1161-1173.
50. Novak A., Hsu S.C., Leung-Hagesteijn C., Radeva G., Papkoff J., Montesano R., et al. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc Natl Acad Sci USA. 95:1998;4374-4379.